These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33891694)

  • 1. Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom.
    Danese MD; Pemberton-Ross P; Catterick D; Villa G
    Eur J Prev Cardiol; 2021 Apr; 28(3):335-343. PubMed ID: 33891694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
    Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
    JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
    Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry.
    Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Ikeda Y; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
    Clin Cardiol; 2016 Nov; 39(11):670-677. PubMed ID: 27588731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of subsequent myocardial infarction, stroke, and death in stable post-myocardial infarction patients: A nationwide cohort study.
    Chen DY; Li CY; Hsieh MJ; Chen CC; Hsieh IC; Chen TH; Chen SW; Wang CY; Chang SH; Lee CH; Tsai ML; Ho MY; Yeh JK; Chang CJ; Wen MS
    Eur Heart J Acute Cardiovasc Care; 2019 Oct; 8(7):634-642. PubMed ID: 28895425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Lauder L; Mancia G; Redon J; Schmieder RE; Sliwa K; Marx N; Weber MA; Williams B; Yusuf S; Mann JFE; Mahfoud F
    J Hypertens; 2021 Aug; 39(8):1602-1610. PubMed ID: 34188004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
    Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
    Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
    Boden WE; Cherr GS; Eagle KA; Cannon CP; Califf RM; Hirsch AT; Alberts MJ; Criqui M; Creager MA; Massaro JM; D'Agostino RB; Steg PG; Bhatt DL;
    Crit Pathw Cardiol; 2010 Sep; 9(3):116-25. PubMed ID: 20802264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year cardiovascular event rates in outpatients with atherothrombosis.
    Steg PG; Bhatt DL; Wilson PW; D'Agostino R; Ohman EM; Röther J; Liau CS; Hirsch AT; Mas JL; Ikeda Y; Pencina MJ; Goto S;
    JAMA; 2007 Mar; 297(11):1197-206. PubMed ID: 17374814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
    Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
    Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine and risk of cardiovascular disease in women.
    Kurth T; Gaziano JM; Cook NR; Logroscino G; Diener HC; Buring JE
    JAMA; 2006 Jul; 296(3):283-91. PubMed ID: 16849661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
    Zhang Q; Wang A; Zhang S; Li N; Chen S; Zhang Y; Zhou Y; Wu S; Zhao X
    Atherosclerosis; 2017 Jul; 262():1-7. PubMed ID: 28463782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry.
    Weimar C; Diener HC; Alberts MJ; Steg PG; Bhatt DL; Wilson PW; Mas JL; Röther J;
    Stroke; 2009 Feb; 40(2):350-4. PubMed ID: 19023098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort.
    Mortensen MB; Nordestgaard BG
    Lancet; 2020 Nov; 396(10263):1644-1652. PubMed ID: 33186534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry.
    Hejjaji V; Ellerbeck EF; Jones PG; Pacheco CM; Malik AO; Chan PS; Spertus JA; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009960. PubMed ID: 38318702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.